WO2001038501A3 - Serine protease humaine - Google Patents

Serine protease humaine Download PDF

Info

Publication number
WO2001038501A3
WO2001038501A3 PCT/US2000/031819 US0031819W WO0138501A3 WO 2001038501 A3 WO2001038501 A3 WO 2001038501A3 US 0031819 W US0031819 W US 0031819W WO 0138501 A3 WO0138501 A3 WO 0138501A3
Authority
WO
WIPO (PCT)
Prior art keywords
serine protease
human serine
protease family
zfaix1
fibrinolysis
Prior art date
Application number
PCT/US2000/031819
Other languages
English (en)
Other versions
WO2001038501A2 (fr
Inventor
James L Holloway
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU16245/01A priority Critical patent/AU1624501A/en
Publication of WO2001038501A2 publication Critical patent/WO2001038501A2/fr
Publication of WO2001038501A3 publication Critical patent/WO2001038501A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Selon l'invention, les membres de la famille des sérines protéases jouent un rôle dans des processus surveillés attentivement, tels que la coagulation sanguine, la fibrinolyse et la production hormonale. Ces enzymes sont également utilisées dans une variété de contextes diagnostics, thérapeutiques et industriels. Zfaix1 est un nouveau membre de la famille des sérines protéases.
PCT/US2000/031819 1999-11-23 2000-11-17 Serine protease humaine WO2001038501A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU16245/01A AU1624501A (en) 1999-11-23 2000-11-17 Human serine protease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44837699A 1999-11-23 1999-11-23
US09/448,376 1999-11-23

Publications (2)

Publication Number Publication Date
WO2001038501A2 WO2001038501A2 (fr) 2001-05-31
WO2001038501A3 true WO2001038501A3 (fr) 2002-02-21

Family

ID=23780070

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/031819 WO2001038501A2 (fr) 1999-11-23 2000-11-17 Serine protease humaine

Country Status (2)

Country Link
AU (1) AU1624501A (fr)
WO (1) WO2001038501A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2003515338A (ja) * 1999-12-02 2003-05-07 クリスチャン イェンセニウス，イェンス 補体結合酵素、ｍａｓｐ−３、及びその使用
CA2402763A1 (fr) * 2000-03-17 2001-09-27 Incyte Genomics, Inc. Proteases
WO2002010404A2 (fr) * 2000-07-27 2002-02-07 Bayer Aktiengesellschaft Regulation de la serine protease humaine du type masp

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001040451A2 (fr) * 1999-12-02 2001-06-07 Jens Christian Jensenius Masp-3: enzyme de fixation du complement, et son utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001040451A2 (fr) * 1999-12-02 2001-06-07 Jens Christian Jensenius Masp-3: enzyme de fixation du complement, et son utilisation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; August 2000 (2000-08-01), DAHL M R ET AL: "Mannan-binding lectin associated serine protease 3 (MASP-3): A new component of the lectin pathway of complement activation.", XP002172893, Database accession no. PREV200000389401 *
DATABASE EMBL 30 June 1999 (1999-06-30), MUZNY D ET AL: "Homo sapiens 3q27 BAC RP11-208N14", XP002172894 *
IMMUNOPHARMACOLOGY, vol. 49, no. 1-2, August 2000 (2000-08-01), XVIIIth International Complement Workshop;Salt Lake City, Utah, USA; July 23-27, 2000, pages 79, ISSN: 0162-3109 *

Also Published As

Publication number Publication date
AU1624501A (en) 2001-06-04
WO2001038501A2 (fr) 2001-05-31

Similar Documents

Publication Publication Date Title
TR199902692T2 (xx) Serin proteaz inhibit�rleri.
GEP20012448B (en) Tissue Plasminogen Activators (Improved Variants)
WO2000054799A3 (fr) Medicament destine au traitement du diabete
WO2001083782A3 (fr) Nouvelles proteases
WO2002000860A3 (fr) Nouvelles proteases
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
WO1998046771A3 (fr) Mocarhagine hautement purifiee, une protease du venin de cobra, polynucleotides codant cette protease et des proteases associees, et utilisations therapeutiques correspondantes
NO994858D0 (no) Forbindelser og preparater til behandling av sykdommer assosiert med serinprotease, spesielt tryptase aktivitet
WO2001038501A3 (fr) Serine protease humaine
EP1997510A8 (fr) Facteurs activant des plasminogènes non neurotoxiques destinés au traitement de l'apoplexie
WO2001066771A3 (fr) Serine-protease humaine
JPS6475431A (en) Novel protease preparation
GB9216558D0 (en) Modified proteases
EP0373771A3 (fr) Nouvelles utilisations pharmaceutiques des cystatines
AU2353688A (en) Modified tissue plasminogen activator
WO2001046230A3 (fr) Polypeptide zkun11 a domaine de kunitz
AU695190B2 (en) Substance FA-70D, process for producing the same, and uses thereof
WO2002014359A3 (fr) Serpine humaine zserp15
IE890270L (en) Proteins derived from human alpha 2 plasmin inhibitor
TW288046B (en) Nucleotide sequence of cDNA of a thrombin-like enzyme (ancrod) from Calloselasma rhodostoma and amino acid sequence of ancrod therefrom
WO2001038534A3 (fr) Serpine humaine
AU9066198A (en) Use of bromelain proteases for inhibiting blood coagulation
SUMI et al. Enzymatic production of acid stable trypsin-plasmin inhibitor (ASTI) in human plasma
EP0957110A3 (fr) Tubulines lyophilisées
WO2002026949A3 (fr) Nouvelles proteases humaines et polynucleotides les codant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)